Quorum-sensing-regulated virulence factors in Pseudomonas aeruginosa are toxic to Lucilia sericata maggots by Andersen, A. S. et al.
Quorum-sensing-regulated virulence factors in
Pseudomonas aeruginosa are toxic to Lucilia
sericata maggots
A. S. Andersen,
1,2,3 B. Joergensen,
2 T. Bjarnsholt,
3 H. Johansen,
3
T. Karlsmark,
2 M. Givskov
3 and K. A. Krogfelt
1
Correspondence
A. S. Andersen
aea@ssi.dk
1Statens Serum Institut ABMP, Artillerivej 5, Copenhagen S, Denmark
2Copenhagen Wound Healing Center, Bispebjerg Hospital, Bispebjerg bakke 23, Copenhagen NV,
Denmark
3University of Copenhagen Faculty of Health Sciences, Blegdamsvej 3B, 2200 Copenhagen N,
Denmark
Received 25 July 2009
Revised 3 November 2009
Accepted 4 November 2009
Maggot debridement therapy (MDT) is widely used for debridement of chronic infected wounds;
however, for wounds harbouring specific bacteria limited effect or failure of the treatment has
been described. Here we studied the survival of Lucilia sericata maggots encountering
Pseudomonas aeruginosa PAO1 in a simple assay with emphasis on the quorum-sensing (QS)-
regulated virulence. The maggots were challenged with GFP-tagged P. aeruginosa wild-type
(WT) PAO1 and a GFP-tagged P. aeruginosa DlasR rhlR (DRR) QS-deficient mutant in different
concentrations. Maggots were killed in the presence of WT PAO1 whereas the challenge with the
QS mutant showed a survival reduction of ~25% compared to negative controls. Furthermore,
bacterial intake by the maggots was lower in the presence of WT PAO1 compared to the PAO1
DRR mutant. Maggot excretions/secretions (ES) were assayed for the presence of QS inhibitors;
only high doses of ES showed inhibition of QS in P. aeruginosa. Thus P. aeruginosa was shown to
be toxic to L. sericata maggots. This, coupled to the preferential feeding by the maggots and
reduced ingestion of P. aeruginosa, could explain MDT failure in wounds colonized by
P. aeruginosa. Wounds heavily colonized with P. aeruginosa should be a counterindication for
MDT unless used in combination with a pre-treatment with other topical therapeutics targeting
P. aeruginosa.
INTRODUCTION
Maggot debridement therapy (MDT) of chronic wounds is
a controlled application of commercially produced sterile
larvae from the greenbottle fly Lucilia sericata. The
application of maggots in a clinical setting is performed
either in sealed nylon pouches/bags that allow fluid and gas
exchange with the wound environment (Biobags), or as a
free-range version of the therapy, where the maggots are
applied directly to the wound bed, sealed in with a covering
net and dressing (Sherman et al., 2000). The treatment
modality is a standard procedure at wound care centres all
over the world and is a safe therapeutic option. Many
patients with devitalized and necrotic chronic wounds are
ideal candidates for MDT. The maggots gently and
thoroughly remove necrotic tissue by mechanical action
and by extracorporeal proteolytic digestion during a
3–5 day application, after which they are rinsed from the
wound or the bag is simply removed, leaving the healthy
granulation tissue unharmed. The maggots are additionally
believed to secrete antimicrobial compounds into the
wound, kill ingested bacteria in their gut and alkalinize the
wound (Mumcuoglu et al., 2001; Sherman et al., 2000;
Thomas et al., 1999), and their secretions inhibit multiple
neutrophil and monocyte pro-inflammatory responses
(van der Plas et al., 2007, 2009) – all effects beneficial in
order to heal a chronic wound. However, a few reports
have stated that MDT in some cases facilitates an infection,
especially when specific bacterial species are present in the
wound prior to treatment (Fleischmann et al., 2004;
Fleischmann, 2007). MDT has also been observed to fail
in some cases due to the death of the maggots in the wound
environment or to low feeding activities of the maggots
(Fleischmann, 2007; Renner et al., 2008).
A major beneficial effect of MDT is the reduction of the
wound bio-burden. The bactericidal effect of maggot
excretions/secretions has been described against a broad
Abbreviations: ES, excretions/secretions; MDT, maggot debridement
therapy; QS, quorum sensing; QSI, quorum sensing inhibiting; SSI,
Statens Serum Institut; PON1, paraoxonase-1.
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cillin-resistant Staphylococcus aureus (Bexfield et al., 2008;
Bowling et al., 2007; Cazander et al., 2009a), but they are less
effective against Gram-negative bacteria, in particular
Pseudomonas aeruginosa (Cazander et al., 2009a; Jaklic et al.,
2008; Kerridge et al., 2005; Steenvoorde & Jukema, 2004).
Chronic wounds harbour mixed microbial communities
(Howell-Jones et al., 2005) and in particular it has been
shown that P. aeruginosa increases the wound size when
colonizing chronic venous leg ulcers (Gjo ˜dsbo ˜l et al.,2 0 0 6 ) .
Wounds are in general susceptible to infection due to the
development of microbial communities within and around
the wound environment (Bowler, 2003), and can act as
reservoirsofantibioticresistant micro-organismsinhospitals
and nursing homes (Day & Armstrong, 1997). It is suggested
that bacteria during colonization of chronic wounds are
growing in microcolonies also known as biofilms (Bjarnsholt
et al., 2008; Davis et al., 2008; James et al., 2008; Kirketerp-
Moller et al., 2008; Serralta et al., 2001).
Biofilms and the chemically based bacterial cell commun-
ication denoted quorum sensing (QS) play important roles
in a multitude of human infections (Costerton et al., 1999).
In P. aeruginosa, the QS system is divided into two
hierarchically ordered systems termed las and rhl, with the
las system positioned higher in the signal cascade. Both
systems consist of a specific pair of genes, lasI/lasR and
rhlI/rhlR respectively (Pesci & Iglewski, 1997). The I-genes
encode synthases that synthesize either 3-oxo-dodecanoyl-
homoserine lactone (3-oxo-C12-HSL) in the las system or
butyrylhomoserine lactone (C4-HSL) in the rhl system.
The R genes encode regulatory proteins which, guided by
the abundance and density of C4-HSL and 3-oxo-C12-
HSL, activate gene expression of numerous target genes
including expression of virulence factors, such as elastase,
(alkaline) proteases, rhamnolipids, pyocyanin and cyanide
(Pearson et al., 1997). Interconnecting the systems in the
QS hierarchy is the quinolone signal (PQS) system that
cooperatively regulates expression of rhlI and lasB (Diggle
et al., 2003). Several opportunistic pathogenic bacteria such
as P. aeruginosa and S. aureus show QS-mediated
organization (Costerton et al., 1999; Qazi et al., 2006;
Rasmussen & Givskov, 2006), thus increasing speculation
regarding the involvement of QS and biofilm formation in
the chronicity of wounds.
An exotoxin of Pseudomonas fluorescens has been shown to
be toxic to larvae and pupae of the domestic house fly
Musca domestica (Padmanabhan et al., 2005), although the
metabolite and mode of action are not known.
Furthermore, maggot excretions/secretions are highly
effective against S. aureus biofilms in vitro but less effective
against P. aeruginosa biofilms (van der Plas et al., 2008).
All the above factors inspired us to design a solid-medium
assay for assessing the effect of bacterial challenges on
maggot survival in vitro in order to investigate the possible
role of QS-controlled virulence factors in P. aeruginosa as a
cause of MDT failure.
METHODS
Maggots and maggot secretions. In order to mimic the patient
situation with respect to logistics and larval life stages at application
in the wound, larvae were purchased through and delivered to the
Copenhagen Wound Healing Centre (CWHC) from a commercial
supplier (BioMonde or Zoobiotic) via the usual procedures at the
CWHC. Upon delivery, vials of sterile first-instar larvae of L. sericata
were used for initiation of the experiments within a timeframe of 2 h.
Additionally, maggot excretions/secretions (ES) were collected from
300 aseptically reared first-instar maggots (ES1) and from 400
aseptically reared and actively feeding second–third-instar maggots
(ES2), approximately 5 g wet weight. The maggots used for ES
collection were a kind gift from Dr Alun Morgan of Zoobiotic Ltd,
Bridgend, UK. Maggots were added to a sterile container, supple-
mented with 200 ml sterile MilliQ water per g of maggots and
incubated at 30 uC for 60 min in the dark; the surplus fluid was then
siphoned off and centrifuged at 1300 g for 5 min to remove
particulate matter. The supernatant was checked for sterility and
stored at 220 uC (van der Plas et al., 2008). Total protein
concentration of ES was determined with the Pierce Micro BCA
protein assay kit (Fisher Thermo Scientific) according to the
manufacturer’s instructions.
Micro-organisms. The wild-type (WT) P. aeruginosa was obtained
from the Pseudomonas Genetic Stock Center (http://www.pseudomonas.
med.ecu.edu; strain PAO0001, hereafter PAO1). The P. aeruginosa
DlasR rhlR mutant (DRR) (Bjarnsholt et al., 2005) was constructed
using previously described knockout systems (Beatson et al., 2002).
This isolate has served as DNA source for the Pseudomonas
Genome Project (http://www.pseudomonas.com) and subsequently
as template for the design of the P. aeruginosa GeneChip
(Affymetrix). The knockout mutants were verified by Southern
blot analysis and by screening for acylhomoserine lactone
production (QS signals). A stable green fluorescent protein
(GFP) constitutively expressed on plasmid pMRP9 (Davies et al.,
1998) was used to tag the bacteria. PAO1 carrying the plasmid
pMHLB, containing a transcriptional fusion of the LasR-regulated
lasB promoter and the gene for an unstable version of GFP, was
used for the LasR inhibition assay (Hentzer et al., 2002). A similar
strain for the RhlR inhibition assay was used, the only difference
being a replacement of the lasB::gfp construct on the pMHLB
plasmid with a rhlA::gfp transcriptional fusion (Yang et al., 2009).
Survival assay of larvae on plates. The larvae were aseptically
transferred onto 9 cm 5% blood agar Petri dishes (SSI art. nr 677)
(hereafter referred to as plates), treated with five different precondi-
tions and each covered with a gas-permeable sterile pre-cut piece of
Tegapore wound contact material (3M) tightly taped to the top of the
plates. This seal allowed ventilation and prevented escape of the
larvae. Precondition 1 (control plates): plates were incubated 17 h
overnight (O/N) at 37 uC prior to the assay. Precondition 2 (WT
low): 6610
2 c.f.u. WT PAO1 bacteria were spread on the plates and
incubated O/N at 37 uC prior to the assay, resulting in dispersed
growth of single colonies of bacteria. Precondition 3 (WT high):
6610
5 c.f.u. WT PAO1 bacteria were spread on the plates and
incubated O/N at 37 uC prior to the assay, resulting in a dense lawn of
bacteria. Precondition 4 (DRR low): 6610
2 c.f.u. DRR PAO1 bacteria
were spread on the plates and incubated O/N at 37 uC prior to the
assay, resulting in dispersed growth of single colonies of bacteria.
Precondition 5 (DRR high): 6610
5 c.f.u. DRR PAO1 bacteria were
spread on the plates and incubated O/N at 37 uC prior to the assay,
resulting in a dense lawn of bacteria. Plates similar to preconditions 2
and 3 were additionally supplemented to total concentrations of
10 mM (precondition 6) and 75 mM (precondition 7) with the known
quorum-sensing-inhbiting (QSI) compound furanone C30 (Hentzer
et al., 2003a) prior to inoculation in order to synthetically induce a
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maggots were added per plate for the different preconditions (n5100
for preconditions 1–5 and n530 for preconditions 6 and 7) and
incubated at 37 uC in the dark.
Maggot survival was monitored at 2 h intervals for the first 70 h and
subsequently checked after 90 h (at assay termination), mimicking
the 3–4 days duration of MDT in the clinic. Maggot survival was
monitored by removal of immobile/inactive maggots into sterile Petri
dishes dedicated to each assay plate and recorded. Maggot death was
verified by circling the immobile maggots with a permanent marker
and the observation of no movement for 4 h. In the case of movement
maggots were reintroduced into the assay plate from which they had
been removed. Maggots contained in 262 cm biobags (BioMonde)
(50 maggots per bag) were also challenged on the WT PAO1 high and
DRR PAO1 high assay plates independently of the other experiments.
The bags were allowed to lie on top of the inoculated plates for 90 h
and the clearing zone beneath the bags was monitored. Maggot
viability was observed after 90 h, but it was not monitored during the
assay since this estimate was impossible to perform through the bags.
Maggot survival was analysed by Kaplan–Meier survival plots using
GraphPad Prism Version 4.0 (GraphPad Software Inc.). Comparison
of survival plots was performed using a logrank test.
Larvae bacterial feeding assay. Five first-instar maggots per plate
were added to three plates with either the WT high precondition or
the DRR high precondition and allowed to forage for 20 min. The
maggots were then transferred to sterile Petri dishes and briefly kept
at 220 uC for 3 min in order to slow down their activity level, after
which they were photographed in snapshot series of 20 pictures per
maggot using a fluorescence microscope. A representative image from
the anterior part of each maggot containing the larval crop from each
setup was selected and evaluated visually. Crop fluorescence was used
as an indication of the amount of food uptake by the maggots when
compared to the minimal auto-fluorescence from maggots taken from
plates without bacteria. All microscope observations and image
acquisitions were performed with a Zeiss LSM 510 CLSM equipped
with lasers, detectors and filter sets for monitoring of green
fluorescence. Images were obtained using a 106/1.3 objective.
Larvae bacterial chemotaxis assay. Four sterile first-instar
maggots were added to 1-day-old c.f.u. spot-plates containing either
DRR PAO1 or WT PAO1 in spots of increasing bacterial density and
areas of plate not containing bacteria, thereby presenting the maggots
with movement preference options. Plates were incubated for 2 h at
37 uC and inspected with respect to the maggot’s movement as
revealed by tracks in the bacterial spots. Experiments were performed
in triplicate.
QS inhibition. Fifteen third-instar maggots taken from the
precondition 1 plates after 90 h were added to duplicate sets of three
1.5 ml tubes containing 1 ml ethyl acetate (Full 1), 1 ml methanol
(Full 2), or 1 ml sterile MilliQ water (Full 3), respectively, and
homogenized with a sterile plastic pestle. Full maggot samples were
cleared of particulate matter by centrifugation and 25 ml of the
resulting extract was tested for the presence of general QSI
compounds along with 25 ml of the collected ES using the QSIS1
selector assay as described by Rasmussen et al. (2005). ES1 and ES2
were also tested, in concentrations ranging from 0.5 to 400 mg total
protein, for the ability to inhibit lasB and rhlA in P. aeruginosa in
vitro, as described by Yang et al. (2009). To establish the presence of a
dose–response relationship to ES1 and ES2, twofold serial dilutions
were made with growth medium (ABT with 0.5%, w/v, Casamino
acids and 0.5% glucose) in a microtitre dish. Each well contained
150 ml ES solution (diluted). Subsequently, 150 ml of an overnight
culture (diluted 1:100) of either P. aeruginosa PAO1 lasB-gfp(ASV)
or P. aeruginosa PAO1 rhlA-gfp(ASV) was added. Growth was
monitored as OD450 over a time-course of 16 h, and GFP expression
was measured (excitation/emission wavelength 485/535 nm respect-
ively).
RESULTS
Maggot survival
A novel plate assay was developed in order to establish
whether QS-dependent virulence factors are detrimental to
the maggots. To monitor maggot survival in vitro WT
PAO1 and DRR PAO1 strains were used. In Fig. 1, the
Kaplan–Meier survival analysis of the maggots shows that
the presence of WT PAO1 in both the high and low dose
severely impaired maggot survival compared to the control
plates, with almost 0% survival for the maggots subjected
to the WT high precondition after 20 h.
A similar final mortality was seen for the WT low
precondition, but with a 15 h lag time compared to the
WT high precondition. The logrank test showed that all
survival curves were significantly different from the control
curve (P,0.0001) and all curves were individually
significantly different from each other (P,0.0001), except
for the comparison between the DRR high precondition
and the DRR low precondition. This confirmed our
suspicion that QS-controlled virulence factors in part were
causing impaired survival of the maggots. Comparable
results were seen for the maggots confined in Biobags
(results not shown).
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Fig. 1. Kaplan–Meier survival plots for the five precondition
treatments (n5100 for each precondition). Curves were tested
with a logrank test as to whether they were significantly different.
All survival plots were significantly different from the control ($)
(P,0.0001) and all plots were individually significantly different
from each other (P,0.0001) except for the comparison between
the DRR high precondition (.) and the DRR low precondition (h),
which were not significantly different. e, WT high precondition;
g, WT low precondition.
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In order to explore other possibilities besides the QS-
controlled toxicity, we aimed to use scanning confocal laser
microscopy to visualize the ingested bacteria within the
maggots via the GFP tag. As shown in Fig. 2, the maggots
that foraged on the plates with high numbers of WT PAO1
showed little fluorescence in the anterior part of the body,
corresponding to the crop where the maggots initially
process ingested food. This was in marked contrast to
maggots from plates with DRR PAO1 in high numbers,
where massive fluorescence was observed in the anterior
part of the maggots corresponding to the location of the
crop. Technical problems during fixation of maggots
prevented us from getting quantitative measurements of
the actual fluorescence intensity, so the data are repres-
entative images from the WT high, DRR PAO1 high and
control plates. The data strongly indicate a reduced
bacterial uptake by the maggots on the WT high plates.
The high intake of DRR PAO1 compared to the WT PAO1
could suggest that the presence of P. aeruginosa actively
expressing QS-controlled virulence factors leads to reduced
food intake by L. sericata maggots.
QS-controlled factors influence maggot
chemotaxis
As a preliminary indicative experiment to study whether
maggots will actively move away from high concentrations
of QS-producing P. aeruginosa, a simple experiment was
carried out on spot-plates used for the c.f.u. determinations
for the precondition plates. As shown in Fig. 3, the maggots
seemed to actively avoid the areas with the high
concentrations of WT PAO1 as compared to the same
concentrations of the DRR PAO1. This is comparable to
observations from the survival assays, where the maggots
from the WT PAO1 plates were recovered dead positioned
on the Tegapore seal, indicating that the maggots will avoid
high concentrations of WT PAO1.
QS inhibitors in maggot extracts and ES
Maggot ES and full maggot extracts were tested using the
QSIS1 system and specifically for P. aeruginosa QSI activity.
As seen in Fig. 4(a, b), the addition of the ethyl acetate and
methanol extracts from the full maggots showed a general
QSI activity, but this was slight as compared to the positive
control patulin shown in Fig. 4(f). ES1 and ES2 did
not appear to convey any QSI effect in the QSIS1 assay
Fig. 4(d, e).
As seen in Fig. 5(a) maggot ES seemed to dose-dependently
inhibit PAO1 rhlA expression, but they inhibited PAO1
lasB expression to a lesser extent (Fig. 5b). Addition of ES2,
even in the highest concentration of 400 mg, to the PAO1
(rhlA-gfp) and PAO1 (lasB-gfp) QS monitoring assays did
not show a bactericidal effect against P. aeruginosa (results
not shown), which is in line with previous reports on the
antimicrobial activity of ES (Cazander et al., 2009a; Jaklic
et al., 2008; Kerridge et al., 2005; Steenvoorde & Jukema,
2004).
DISCUSSION
In order to test the in vitro effect of bacterial wound
pathogens upon survival of maggots of the blow fly L.
sericata, a simple assay was developed. The assay was used
to elicit an explanation for the treatment failure seen
(a)
(c)
(b)
Fig. 2. (a, b) Representative pictures of the
anterior part of maggots having foraged on a
plate with the WT high precondition (a) or the
DRR high precondition (b). (c) Representative
overexposed picture (5 s) of the anterior part
of a maggot having foraged on a negative
control plate without bacteria, indicating min-
imal background fluorescence. Arrows indicate
crop position. Scale bars, 0.5 mm.
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colonized/infected with P. aeruginosa. In the majority of
cases MDT is a safe therapeutic option for debridement of
otherwise very difficult to treat cases of chronic wounds.
Maggot survival is affected by transport and storage
conditions (Zhang et al., 2008), here reflected in our assay,
which did not confer 100% survival of the maggots on the
control plates (Fig. 1).
The slower onset of maggot mortality resulting from the
WT PAO1 high compared to the WT PAO1 low condition
may in part be explained by the observed reduced food
uptake (Fig. 2) coupled to the preferential movement of the
maggots away from areas of the assay plates harbouring
WT PAO1 (Fig. 3). Thus WT PAO1 in the low
precondition plates accumulates to critical mass/toxicity
when unchallenged by the maggots, eventually resulting in
100% mortality. The reduced survival of the maggots
seemed to be associated with the expression of QS-
controlled virulence factors by the bacteria, as an increase
in survival was seen in both DRR PAO1 high and low
preconditions, in which the bacteria do not express QS-
dependent virulence factors. The observed impairment of
maggot survival in the DRR PAO1 high and low conditions
as compared to the negative controls may be attributed to
non-QS-controlled bacterial metabolites. However, the
survival and nutritional status of the maggots on the
DRR precondition plates was, as shown in Figs 1 and 2,
significantly improved compared to that on the WT
precondition plates. In order to rescue the maggots a QSI
compound, furanone C30, was supplemented to plates, but
it did not sufficiently inhibit the WT PAO1 effect. The
solid-media assay developed here does not allow the
continuous supplementation that is required for a
sufficient QSI effect (Hentzer et al., 2003b). Since activities
of the maggots in MDT take place on wound surfaces,
performing the experiments in liquid media was not
considered an alternative.
Our results indicate that the problems that clinicians
experience with P. aeruginosa and MDT are caused by P.
aeruginosa QS-controlled toxicity to the maggots. In
addition, the failure of maggots to eliminate P. aeruginosa
(a) (b)
Fig. 3. (a) WT PAO1 c.f.u. spot-plate with four maggots. (b) DRR PAO1 c.f.u. spot-plate with four maggots. Both plates were
incubated in the dark for 120 min at 37 6C. Maggot movement is indicated by tracks on the plates and is reduced on (a) as
compared to (b). Scale bar, 1 cm.
Fig. 4. (a–e) QSIS1 assay: (a) 25 ml ethyl acetate full maggot
extract, (b) 25 ml methanol full maggot extract, (c) 25 ml MilliQ
water full maggot extract, (d) 150 mg ES1, (e) 150 mg ES2. (f)
Positive control: 1 mM patulin. (g) Negative control: 25 ml1 0 %
methanol.
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the wound micro-niches that exist within chronic wounds
(Andersen et al., 2007; Fazli et al., 2009; Kirketerp-Moller
et al., 2008). Therefore, wounds heavily colonized with P.
aeruginosa should be a counterindication for MDT or
should be treated with a substantially higher number of
maggots or more frequent dressing/maggot changes
(Steenvoorde & Jukema, 2004; van der Plas et al., 2008).
However, adding more maggots should be weighed against
the added costs of this treatment regime as opposed to
supplementing or pre-treating the wound with other
topical therapeutics.
The QSIS1 assay of full maggot extracts in different
solvents showed a limited QSI activity. ES did, at high
concentrations, inhibit PAO1 rhlA expression and to a
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within ES at these concentrations interfere with the QS-
controlled induction of lasB. However, since 400 mg in this
limited volume is in the upper part of the therapeutic range
of ES that can be achieved locally in wounds during MDT
(van der Plas et al., 2008), this inhibition is not clinically
relevant, especially in heavily colonized wounds.
Comparable results were seen for both ES1 and ES2. ES
in concentrations ranging from 0.2 to 200 mg did not
mimic or antagonize the actions of various short- and
long-chained N-acylhomoserine lactones, even though
addition of ES led to S. aureus and P. aeruginosa biofilm
breakdown in vitro (Cazander et al., 2009b; van der Plas et
al., 2008). However, ES in concentrations ranging from 100
to 400 mg in our study seemed to inhibit expression of lasB,
even though it did not abrogate it. The mechanisms and
compounds within ES leading to the reduced expression of
lasB in this study will be the subject of further
investigations.
A study by Stoltz et al. (2008) elegantly showed that using
transgenic paraoxonase-1 (PON1)-expressing Drosophila
melanogaster flies rescued the flies in an abdominal
infection model from P. aeruginosa-induced lethality. The
reduced virulence of P. aeruginosa was dependent upon
enzymic lactonase activity of PON1 not normally expressed
in D. melanogaster. PON1 degrades and disrupts the small
autoinducer acylhomoserine lactone QS molecules (Ozer
et al., 2005). These findings support the lethality observed
in our study due to P. aeruginosa. Although the study by
Stoltz et al. (2008) was performed in a different insect, D.
melanogaster, and with direct infection of adult flies,
toxicity of P. aeruginosa showed QS dependence. In our
study the mere presence of large quantities of WT P.
aeruginosa without any predisposition of the maggots via
chemical or physical challenge was toxic to the maggots. A
clinical implication of these results is that wounds heavily
colonized with P. aeruginosa should be a counterindication
for MDT unless used in combination with a pre-treatment
with other topical therapeutics targeting P. aeruginosa. The
specific QS-controlled P. aeruginosa virulence factors
involved in the reduced maggot survival will be the subject
of further research.
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